Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neurology(R) Neuroimmunology & Neuroinflammation|October 3, 2019
Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation studySvenja Kramer, Arash Haghikia, Claudia Bang, et al.Neurology and Therapy|June 18, 2026
Prebiotics and SCFA Alleviate Parkinson's-Related Constipation: Results from a Randomized Controlled TrialTobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.Cells|February 12, 2020
Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's DiseaseTobias Hegelmaier, Marco Lebbing, Alexander Duscha, et al.Frontiers in Neurology|June 5, 2026
From inflammation to neurodegeneration: an exploratory pilot study of a diagnostic framework for progression in MSTobias Hegelmaier, Khaldoon O Al-Nosairy, Alexander Duscha, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2014
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosisAiden Haghikia, Simon Faissner, Derek Pappas, et al.Med (New York, N.Y.)|July 24, 2025
Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitisTobias Hegelmaier, Denise Wolleschak, Vaia Pappa, et al.Immunity|October 22, 2015
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small IntestineAiden Haghikia, Stefanie Jörg, Alexander Duscha, et al.Brain Communications|June 19, 2024
Propionic acid promotes neurite recovery in damaged multiple sclerosis neuronsBarbara Gisevius, Alexander Duscha, Gereon Poschmann, et al.Scientific Reports|December 5, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective studyTobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.Cell|March 12, 2020
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Barbara Gisevius, Sarah Hirschberg, et al.Pageof 2